Pharmacorp Rx Inc. (PCRX)
TSXV
Closed
Oct 9, 2026
Day's Range
0.410052 wk Range
0.3900Overview - PCRX - Pharmacorp Rx Inc.
Key Statistics
Valuation
Enterprise Value
53.92M
P/E (Trailing)
‪23.50‬
P/E (Forward)
‪18.00‬
Price / Sales (TTM)
‪3.01‬
Price / Book
‪1.38‬
EV / EBITDA
‪-206.16‬
Profitability
Gross Margin
‪40.31%‬
Profit Margin
‪-3.88%‬
Operating Margin
‪-1.54%‬
Return on Assets
‪-1.64%‬
Return on Equity
‪-2.50%‬
Ownership
Shares Outstanding
174.08M
Float
155.52M
Held by Insiders
‪8.30%‬
Held by Institutions
‪11.84%‬
Price stats
Beta
‪-4.28‬
50-Day Avg
‪0.4767‬
200-Day Avg
‪0.4663‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
3 analysts
Average price target
‪CA$ 0.6667‬Market Cap - PCRX - Pharmacorp Rx Inc.
Peers - PCRX - Pharmacorp Rx Inc.
Peer Comparison
Compared with companies in Pharmaceutical Retailers listed on TSXV.
- PCRXTSXVPharmacorp Rx Inc.82.73MMarket Cap-14.29%52-week change23.50P/E (Trailing)‪-3.88%‬Profit Margin
- HITITSXVHigh Tide Inc.344.98MMarket Cap-29.20%52-week change-6.24P/E (Trailing)‪-4.62%‬Profit Margin
- WOLFTSXVGrey Wolf Animal Health Corp.59.92MMarket Cap+21.96%52-week change35.00P/E (Trailing)‪4.05%‬Profit Margin
- PINKTSXVPerimeter Medical Imaging AI Inc.41.42MMarket Cap+3.70%52-week change3.88P/E (Trailing)‪63.66%‬Profit Margin
Profile Summary - PCRX - Pharmacorp Rx Inc.
About
Pharmacorp Rx Inc. is a prominent player in the pharmaceutical industry, specializing in the development, manufacture, and marketing of prescription medications. Its primary function is to innovate and provide solutions for various health conditions, enhancing patient care and outcomes worldwide. Known for its robust…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
